STATE OF NEW YORK
________________________________________________________________________
1306
2019-2020 Regular Sessions
IN SENATE
January 14, 2019
___________
Introduced by Sens. SERINO, AMEDORE, CARLUCCI, FUNKE, HELMING, JACOBS,
LAVALLE, LITTLE, O'MARA, RANZENHOFER, RITCHIE, SAVINO, SEWARD, TEDISCO
-- read twice and ordered printed, and when printed to be committed to
the Committee on Health
AN ACT to amend the public health law, in relation to creating a pilot
program for Lyme and tick-borne disease testing in children
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Section 206-b of the public health law, as added by chapter
2 260 of the laws of 1988, is amended to read as follows:
3 § 206-b. Lyme and tick-borne disease. 1. Special requirements with
4 respect to Lyme disease diagnosis. [1.] a. Within thirty days after the
5 effective date of this section, the commissioner shall, in writing,
6 order every physician practicing in Suffolk, Westchester and Nassau
7 counties to review the medical records of any patient such physician
8 treated during the period commencing January first, nineteen hundred
9 seventy-five and ending on the date of such order wherein such physician
10 made a diagnosis of juvenile rheumatoid arthritis and to review the
11 circumstances of such diagnosis to reconsider whether such patient has
12 suffered, or is suffering, from the complex, multi-system disorder
13 caused by the bacterium Borrelia burgdorferi, which disease is transmit-
14 ted by the Ixodes dammini tick and is commonly referred to as "Lyme
15 disease". In any case where a hospital or other health care institution
16 or provider has custody or control of the medical records for a patient
17 so diagnosed, upon request such physician shall be entitled to review
18 such medical records for purposes of complying with such order or the
19 commissioner may order any such hospital or other health care institu-
20 tion or provider wherever situated within the state to review such
21 records to reconsider a diagnosis of Lyme disease.
22 [2.] b. The commissioner, upon a showing that there is a reasonable
23 basis to believe that the order provided for herein has not been
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD06975-01-9
S. 1306 2
1 complied with, shall be entitled to apply to a justice of the supreme
2 court for an order requiring any such physician to submit for the
3 commissioner's consideration such records, charts or other pertinent
4 data which will enable him to determine whether there has been full
5 compliance with such order.
6 [3.] c. In any case where a review of such records indicates that a
7 patient may have been, or is, suffering from Lyme disease, such physi-
8 cian shall, consistent with customary and acceptable medical standards,
9 take such action he deems necessary to inform such patient or in the
10 case of a minor, his or her parent or guardian of his findings, conduct
11 additional tests, administer other necessary treatments or refer such
12 patient to another physician for further diagnosis and/or treatment.
13 2. Pilot program for Lyme and tick-borne disease testing in children.
14 a. Subject to appropriation, the commissioner is hereby authorized to
15 establish a pilot program to test for Lyme and tick-borne diseases in
16 children with qualifying diagnoses who present with similar symptoms.
17 Such program, subject to the rules and regulations of the commissioner,
18 shall provide for a test to rule out Lyme and tick-borne diseases in
19 children with a qualifying diagnosis by an approved New York state qual-
20 ified medical research institution or laboratory, at the request of a
21 patient, medical provider, practitioner, hospital, or health care facil-
22 ity. The qualified medical research institution or laboratory shall be
23 responsible for conducting serology testing, or other Lyme and tick-
24 borne disease tests approved by the commissioner, to determine the esti-
25 mated rate of misdiagnosis and co-infections in children and for the
26 development of continuing graduate medical education curriculum address-
27 ing the symptoms and diagnostic tools that can assist in accurately
28 identifying and testing for Lyme and tick-borne diseases in children.
29 The qualified medical research institution or laboratory may work with
30 not-for-profits, professional associations, or academic institutions to
31 develop the continuing graduate medical education curriculum.
32 b. For purposes of this subdivision, the following terms shall have
33 the following meanings:
34 (i) "qualified medical research institution or laboratory" may include
35 academic medical institutions, agencies, public or private organiza-
36 tions, public or private laboratories or any other institution or labo-
37 ratory approved by the department that is conducting Lyme and tick-borne
38 disease research, including but not limited to, testing for the presence
39 of such infections;
40 (ii) "qualifying diagnoses" shall mean juvenile rheumatoid arthritis
41 or any other common medical diagnosis that presents with similar symp-
42 toms to Lyme and tick-borne disease infections that the commissioner
43 deems relevant; and
44 (iii) "children" shall mean all individuals under the age of eighteen
45 who have a qualifying diagnosis.
46 c. The commissioner shall require the qualified medical research
47 institution or laboratory under the pilot program to submit an annual
48 report, which shall include data analyzing the cost, efficiency, and
49 accuracy of tests provided under such program. The report shall also
50 include estimated rates of misdiagnosis or co-infections of Lyme and
51 tick-borne diseases of children with qualifying diagnoses. On or before
52 December thirty-first, two thousand twenty, and annually thereafter, the
53 commissioner shall submit such report to the governor, the temporary
54 president of the senate and the speaker of the assembly.
55 d. Participation in the pilot program shall be voluntary and subject
56 to participation guidelines established by the department. Nothing in
S. 1306 3
1 this subdivision shall establish liability for any reasonable acts or
2 omissions on the part of a hospital, health care institution, or provid-
3 er participating in the program.
4 § 2. This act shall take effect on the ninetieth day after it shall
5 have become a law.
